Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3678069
Max Phase: Preclinical
Molecular Formula: C34H41N5O11S
Molecular Weight: 727.79
Molecule Type: Small molecule
Associated Items:
ID: ALA3678069
Max Phase: Preclinical
Molecular Formula: C34H41N5O11S
Molecular Weight: 727.79
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)OCc1ccccc1)C(=O)N[C@H](/C=C/S(C)(=O)=O)CC(=O)O
Standard InChI: InChI=1S/C34H41N5O11S/c1-20(2)30(33(46)36-23(16-28(40)41)13-14-51(3,48)49)39-32(45)26(15-22-18-35-25-12-8-7-11-24(22)25)37-31(44)27(17-29(42)43)38-34(47)50-19-21-9-5-4-6-10-21/h4-14,18,20,23,26-27,30,35H,15-17,19H2,1-3H3,(H,36,46)(H,37,44)(H,38,47)(H,39,45)(H,40,41)(H,42,43)/b14-13+/t23-,26+,27+,30+/m1/s1
Standard InChI Key: VFANYHPZKZVWGL-ISGROHLWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 727.79 | Molecular Weight (Monoisotopic): 727.2523 | AlogP: 1.62 | #Rotatable Bonds: 18 |
Polar Surface Area: 250.16 | Molecular Species: ACID | HBA: 9 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.66 | CX Basic pKa: | CX LogP: 0.76 | CX LogD: -5.59 |
Aromatic Rings: 3 | Heavy Atoms: 51 | QED Weighted: 0.10 | Np Likeness Score: 0.14 |
1. (2015) Selective caspase inhibitors and uses thereof, |
Source(1):